ArticleDiabetology & metabolic syndrome2026

Metformin versus DPP-4 inhibitors and risk of parkinsonism in type 2 diabetes: an active-comparator cohort study with a landmark design.

Mingyang Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.